Eisai Co., Ltd (ESALY) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research cut shares of Eisai Co., Ltd (NASDAQ:ESALY) from a hold rating to a sell rating in a report released on Friday.

According to Zacks, “Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following divisions: Pharmaceuticals: veterinary drugs other food additives, livestock feed and pharmaceutical production systems and equipment. The Group has overseas consolidated subsidiaries in the United States, Canada, the United Kingdom, France, Germany, East Southeast Asia and South and Central America. “

Eisai Co. (NASDAQ ESALY) traded up 2.98% during mid-day trading on Friday, reaching $55.54. 1,418 shares of the company’s stock were exchanged. The firm’s 50-day moving average is $52.81 and its 200 day moving average is $53.13. The stock has a market capitalization of $15.89 billion and a PE ratio of 58.52. Eisai Co. has a 1-year low of $50.31 and a 1-year high of $65.76.

TRADEMARK VIOLATION WARNING: “Eisai Co., Ltd (ESALY) Downgraded by Zacks Investment Research to Sell” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2017/10/28/eisai-co-ltd-esaly-downgraded-by-zacks-investment-research-to-sell.html.

Eisai Co. Company Profile

Eisai Co, Ltd. is engaged in the research and development, manufacture, sale and import and export of pharmaceuticals. The Company’s businesses include pharmaceutical business and other business. The Company’s segments include Japan (Prescription Medicines, Generics and Diagnostics), Americas (North America, Central and South America), China, Asia (South Korea, Taiwan, Hong Kong, India and ASEAN), EMEA (Europe, the Middle East, Africa and Oceania) and Consumer Healthcare Business-Japan.

Receive News & Ratings for Eisai Co. Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai Co. Ltd and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply